Thank you for your oration nomination
Thank you to everyone who submitted a nomination for the AusBiotech 2026 orations.
Nominations are now closed and are currently being reviewed. We appreciate the time taken to recognise visionary leaders, pioneering researchers and industry trailblazers who have made outstanding contributions to Australia’s life sciences sector.
Successful nominations will help shape the AusBiotech 2026 program and celebrate the individuals driving innovation, leadership and long term impact across the sector.
Millis Oration
Emeritus Professor Nancy Millis was a pioneering microbiologist whose groundbreaking work in fermentation processes and water purity helped shape Australian biotechnology. A trailblazer in genetic engineering, she also played a pivotal role in developing Australia’s biotechnology education, leaving a lasting legacy in both science and academia.
Nomination criteria:
- A distinguished scientist, leader, or pioneer in a field of life sciences including biotechnology.
- Made significant contributions to advancing Australian biotechnology, with a career dedicated to innovation within the Australian scientific community.
- Demonstrate exceptional leadership, embodying the pioneering spirit and values exemplified by the late Emeritus Professor Nancy Millis.
- An Australian who has spent the majority of their career contributing to the advancement of the life sciences industry within Australia.
Depaz Oration
Dr Iris Depaz was a visionary leader, who was dedicated to driving innovation and strategic growth to support the advancement of Australia’s life science industry. With a strong track record in commercialisation, Iris was committed to advancing healthcare solutions and improving patient outcomes for Australians and globally.
Nomination criteria:
- Demonstrated exceptional leadership in commercialisation within Australia's life sciences industry.
- A proven track record of successfully translating scientific innovations into viable, market-ready products that drive significant impact on healthcare outcomes.
- Exhibited outstanding vision and strategic thinking in navigating the complexities of commercialisation, including regulatory, financial, and operational challenges.
- Contributed to the growth of the life sciences industry, promoting collaboration between industry, academia, and government to enhance the commercialisation landscape.
- Exemplify the values of innovation, entrepreneurship, and dedication to improving patient care through effective commercialisation.
